Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Drug-resistant tuberculosis (DR-TB) requires prolonged and complex therapy which is
associated with several adverse drug reactions (ADR). The burden of ADR can affect the …

Rationale: Improving treatment outcomes while reducing drug toxicity and shortening the
treatment duration to∼ 6 months remains an aspirational goal for the treatment of multidrug …

Introduction Tuberculosis (TB) continues to be a leading cause of death in Sub-Saharan
Africa, including Mozambique. While diagnostic methods and total notifications are …

The purpose of this study is to identify at what extent multidrug-resistant tuberculosis (MDR-
TB) diseases effect on environmental health issues in selected provinces of Chinese …

Background Multidrug-resistant tuberculosis (MDR-TB) is a growing concern in meeting
global targets for TB control. In high-income low-TB-incidence countries, a disproportionate …

India has the highest-burden of tuberculosis (TB) patients globally and TB control has been
the focus of the Government of India's Revised National TB Control Programme (RNTCP)[1 …

Background Patient-centered care is pillar 1 of the “End TB” strategy, but little has been
documented in the literature about what this means for people living with rifampicin-resistant …

Multidrug-resistant Tuberculosis (MDR-TB) remains a global health concern. The disease
results in a prolonged treatment and hence, poses a financial burden to affected individuals …

Background Drug-resistant tuberculosis (DR-TB) continues to be a major public health threat
posing a critical challenge to TB treatment and control worldwide. The present study was …